France Oncology Drugs Market Analysis

$3,500.00$7,500.00

  • Type: Therapeutics Area
  • Published : February 2022
  • Region: Europe
  • Country: France
  • Report ID : 5068

  • Format: PPT, PDF

France Oncology Drugs Market: Segmented by Drug Class, Therapy Type, Indication, and Dosage form – Growth, Market Size, Future Prospects & Competitive Analysis, 2021 – 2028

Clear
SKU: 5068 Categories: ,

Report Description of the France Oncology Drugs Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of France Oncology Drugs Drugs market
  • To classify and forecast France Oncology Drugs Market market based on application, drugs, project type, and application.
  • To identify drivers and challenges for France Oncology Drugs market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in France Oncology Drugs market
  • To conduct pricing analysis for France Oncology Drugs Drugs market
  • To identify and analyze the profile of leading players operating in France Oncology Drugs market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Atopic Dermatitis drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Atopic Dermatitis market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

France Oncology Drugs Market Executive Summary

The cancer incidence rate has increased to make it the second leading cause of death after cardiovascular disorders. Environmental factors such as smoking, changing diet patterns, urbanization, and extended post-reproductive lifespan are responsible for this phenomenon and consequently leading to the growth of the market.

Market Size and Key Findings

The France Oncology Drugs market size is at around USD xx billion in 2021 and is projected to reach USD xx billion in 2028, exhibiting a CAGR of xx% during the forecast period.

According to the World Health Organization (WHO), cancer is a growing burden and the number of new cancer cases is going to rise from 18.1 million in 2018 to 29.4 million by 2040. Therefore, the increasing prevalence of cancer is expected to boost the demand for the global oncology cancer drugs market during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

The market is undergoing a significant growth rate due to the factors such as the rising prevalence of different cancers, increasing new drug launch and product approvals, and growing research activities by the pharma companies in this field. Furthermore, the rising awareness regarding cancer among the population is anticipated to favor the global market in the upcoming years.

Market Restraints

Chemotherapy drugs kill cancer cells but also damages normal body cells. This results in the various side effects for the patients. Among the most common side-effects are bone marrow suppression, gastrointestinal disorders, neuropathies, hair loss, fatigue, and skin disorders. Therefore, these adverse effects associated with the oncology drugs are negatively influencing the growth of the market.

COVID-19 impact on “France Oncology Drugs Market” 

The outbreak of COVID-19 has had a positive impact on this market globally. Certain market segments have witnessed a growth in demand for drugs with respect to the COVID-19 emergency.The pharmaceutical companies involved in this market have significantly improved their supply chain management, enhanced the capabilities of their R&D, and invested more their manufacturing management and quality control.

Competitive Landscape

Key Players

Key market players include Pierre Fabre, ENYO Pharma, Inovotion, Xenothera, Zionexa, Sanofi, Casters, Juvise Pharmaceutical, Cellectis, Ipsen Pharma and Others

Products in Pipeline

Sanofi and The University of Texas MD Anderson Cancer Center today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune-therapies, for patients with cancer. The alliance will combine MD Anderson’s clinical trials infrastructure and Sanofi’s pipeline of investigational treatments to lead biomarker-driven clinical studies to better understand how novel cancer drugs work.

Notable Recent Deals

Sanofi, a French pharmaceutical giant, has signed a deal to buy the US-based company, Amunix, which is developing novel cancer treatments that could be the key to defeating this illness.

French drugmaker Ipsen SA (IPN.PA) would buy some assets of Merrimack Pharmaceuticals Inc (MACK.O), including pancreatic cancer drug Onivyde, for up to $1 billion, barely a month after the U.S. company stopped a breast cancer drug trial. The deal would give Merrimack the resources to fund the development of three new compounds targeting pancreatic, lung, and other types of cancers. It would boost Ipsen’s portfolio, which has traditionally focused on endocrinology.

Victoria, British Columbia (CANADA) and Castres (FRANCE), October 07, 2021 – Immunoprecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX Venture: IPA) and the Pierre Fabre pharmaceutical group announced today that IPA’s subsidiary, Talem Therapeutics LLC (“Talem”), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets. This strategic collaboration is expected to help expand Talem’s portfolio of novel antibodies across oncology. It adds to the variety of diverse relationships that the IPA group of companies holds across the pharmaceutical and biotechnology sector.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of France Oncology Drugs Services

France benefits from a universal healthcare system offering wide coverage and large access to drugs. Almost all of the new hematology/oncology cancer drugs assessed had a favorable opinion and are fully reimbursed (100%) by health insurance. A high proportion (66%) of CAV is recognized in oncology. Nevertheless, the over DRG list can inadvertently limit access to these new cancer drugs

1. Report Description of the France Oncology Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. France Oncology Drugs Market Executive Summary
2.1 France Oncology Drugs Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of France Oncology Drugs Market
3.1 Market Growth Drivers Analysis
3.1.1 Rising prevalence of different cancers
3.1.2 Rising awareness regarding cancer
3.1.3 Increasing new drug launch and product approvals
3.1.4 Growing research activities by the pharma companies
3.2 Market Restraints Analysis
3.3 Various side effects of the Chemotherapy
3.4 Covid-19 Market Impact Analysis
3.3.1 Positive impact on outcomes
4. Oncology Drugs Market Segmentation
4.1 By Drug Class Analysis:
4.1.1 Cytotoxic Drugs
4.1.2 Targeted Drugs
4.1.3 Hormonal Drugs
4.2 By Therapy Type Analysis:
4.2.1 Chemotherapy
4.2.2 Targeted Therapy
4.2.3 Immunotherapy
4.3 By Indication Type Analysis:
4.3.1 Lung Cancer
4.3.2 Stomach Cancer
4.3.3 Colorectal Cancer
4.3.4 Cancer
4.3.5 prostate Cancer,
4.3.6 Other
4.4 By Dosage Form Analysis:
4.4.1 Solid
4.4.2 Liquid
4.4.3 Injectable
5. France Oncology Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in France Oncology Drugs Market
6.4 Notable recent deals in France Oncology Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Pierre Fabre Company Overview
Product & Services, Strategies & Financials
7.2 ENYO Pharma Company Overview
Product & Services, Strategies & Financials
7.3 Inovotion Company Overview
Product & Services, Strategies & Financials
7.4 Xenothera Company Overview
Product & Services, Strategies & Financials
7.5 Zionexa Company Overview
Product & Services, Strategies & Financials
7.6 Casters Company Overview
Product & Services, Strategies & Financials
7.7 Juvise Pharmaceutical Company Overview
Product & Services, Strategies & Financials
7.8 Cellectis Company Overview
Product & Services, Strategies & Financials
7.9 Ipsen Pharma Company Overview
Product & Services, Strategies & Financials
7.10 GlaxosmithKline Company Overview
Product & Services, Strategies & Financials
7.11 Novartis Company Overview
Product & Services, Strategies & Financials
7.12 Sanofi Pharmaceuticals Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of France Oncology Drugs Market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development France Oncology Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations

Oncology Drug Market Segmentation

By Drug Class:

The targeted drugs are expected to dominate the global market. The chemotherapy or targeted therapy is aimed at the disease while minimizing the off-target side-effects caused to the normal cells.

  • Cytotoxic Drugs
  • Targeted Drugs
  • Hormonal Drugs

By Therapy Type:

The targeted therapy segment is expected to hold the largest dominant oncology drugs market during the forecast period. The growth is attributed to the growing adoption and preference for targeted drugs in emerging nations.

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy

By Indication Type:

The cancer segment is expected to rise exponentially during the forecast period. The growing prevalence of cancer and rising awareness regarding therapeutics will boost the segment’s growth.

  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Other Cancers

By Dosage Form:

The injectable segment is expected to hold a significant share due to the increasing adoption of cancer treatment biologics.

  • Solid
  • Liquid
  • Injectable

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements